Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arvinas
Biotech
Marea, Ashibio, Arvinas & more—Chutes & Ladders
Cardiometabolic biotech Marea unveils C-suite. Ashibio exits stealth with newly appointed leaders. Arvinas CSO steps into new role after 5 years
Gabrielle Masson
,
Andrea Park
,
Fraiser Kansteiner
Jun 21, 2024 8:30am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am
Novartis pays $150M for Arvinas' prostate tumor protein degrader
Apr 11, 2024 8:04am
Bayer undergoes leadership shake-up—Chutes & Ladders
Mar 22, 2024 9:30am
Arvinas advances anti-resistance cancer drug on sign of efficacy
Jun 8, 2023 9:30am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am